title: Mutant BCR-ABL clones in chronic myeloid leukemia.
authors.forename: Michael S
authors.initials: MS
authors.lastname: Mathisen
authors.forename: Hagop M
authors.initials: HM
authors.lastname: Kantarjian
authors.forename: Jorge
authors.initials: J
authors.lastname: Cortes
authors.forename: Elias
authors.initials: E
authors.lastname: Jabbour
mesh_terms: D024221:Antineoplastic Protocols; D017326:Clinical Trials, Phase III as Topic; D002999:Clone Cells / Q000473:pathology; D019008:Drug Resistance, Neoplasm / Q000187:drug effects / Q000235:genetics; D016044:Fusion Proteins, bcr-abl / Q000235:genetics* / Q000378:metabolism; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy* / Q000235:genetics* / Q000503:physiopathology; D009154:Mutation; D047428:Protein Kinase Inhibitors / Q000008:administration & dosage* / Q000627:therapeutic use; D011505:Protein-Tyrosine Kinases / Q000235:genetics* / Q000378:metabolism; D017211:Treatment Failure
chemical_list: D047428:Protein Kinase Inhibitors; D011505:Protein-Tyrosine Kinases; D016044:Fusion Proteins, bcr-abl